Daniel Newman Mendelson, Director at CHAMPIONS ONCOLOGY, INC. (CSBR), bought 2,000 shares at $6.47 ($13K) on 2023-10-05, disclosed to the SEC on 2023-10-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CSBR | BUY | 2024-01-11 | $19K | — | Filing → |
| CSBR | BUY | 2024-01-10 | $19K | — | Filing → |
| CSBR | BUY | 2024-01-09 | $6K | — | Filing → |